|
Urges parents, teachers and health professionals to protect children from nicotine addiction
U.S. Surgeon General Vice Adm. Jerome M. Adams issued an advisory this week stressing the importance of protecting children from a lifetime of nicotine addiction and associated health risks by immediately addressing the epidemic of youth e-cigarette use.
E-cigarette use among youth has skyrocketed in the past year at a rate of epidemic proportions. According to data from the Centers for Disease Control and Prevention and the Food and Drug Administration’s National Youth Tobacco Survey, the percentage of high school-age children reporting past 30-day use of e-cigarettes rose by more than 75 percent between 2017 and 2018. Use among middle school-age children also increased nearly 50 percent.
The surge in e-cigarette use among our nation’s youth has been fueled by newer cartridge-based devices that have become increasingly popular. Many of these e-cigarettes look like a USB flash drive, making them easy to conceal. One of the most commonly sold versions is JUUL, which now has more than a 70 percent share of the cartridge-based e-cigarette market in the United States. A typical JUUL cartridge, or “pod,” contains about as much nicotine as a pack of 20 regular cigarettes.
E-cigarette use poses a significant – and avoidable – health risk to young people as noted in the 2016 Surgeon General’s report on E-cigarette Use Among Youth and Young Adults. Besides increasing the possibility of addiction and long-term harm to brain development and respiratory health, e-cigarette use may also lead to the use of regular cigarettes that can do even more damage to the body.
Visit https://e-cigarettes.surgeongeneral.gov/ to find resources about the risk of e-cigarettes for youth and young adults. Examples of resources available include a Parent Tip Sheet, Health Care Provider Conversation Card, and several resources in Spanish.
U.S. Department of Health and Human Services
|
|
FOR IMMEDIATE RELEASE Wednesday, December 19, 2018
|
HHS recommends prescribing or co-prescribing naloxone to patients at high risk for an opioid overdose
|
Adm. Brett P. Giroir, MD, assistant secretary for health and senior advisor for opioid policy, today released guidance for healthcare providers and patients detailing how naloxone – the opioid overdose reversal drug – can help save lives and should be prescribed to all patients at risk for opioid complications, including overdose. “Given the scope of the opioid crisis, it’s critically important that healthcare providers and patients discuss the risks of opioids and how naloxone should be used in the event of an overdose,” said Adm. Giroir. “We have begun to see some encouraging signs in our response to the opioid crisis, but we know that more work is required to fully reverse the decades-long epidemic. Co-prescribing naloxone when a patient is considered to be at high risk of an overdose, is an essential element of our national effort to reduce overdose deaths and should be practiced widely.” To reduce the risk of overdose deaths, the guidance released today reinforces and expands upon prior CDC guidelines. It recommends that clinicians prescribe or co-prescribe (prescribed in conjunction with additional medication) naloxone to individuals at risk for opioid overdose, including, but not limited to: individuals who are on relatively high doses of opioids, take other medications which enhance opioid complications or have underlying health conditions. By co-prescribing, or prescribing naloxone to at risk individuals, patients and their loved ones could be better equipped for a possible complications of overdose, including slowed or stopped breathing. Clinicians should also educate patients and those who are likely to respond to an overdose, including family members and friends, on when and how to use naloxone in its variety of forms. Naloxone is an FDA-approved medication that can save a person’s life when administered during an opioid overdose. Naloxone reverses the effects of opioids, such as stopped or slowed breathing. However, for naloxone to revive individuals who have experienced an opioid overdose, it must be in the right hands at the right time and administered within minutes of life-threatening symptoms. Naloxone is available in a variety of forms (nasal spray, injection, auto-injector); and at least one form is covered by most health insurance plans, including Medicaid and Medicare. “Promoting the targeted availability and distribution of overdose-reversing drugs is one of the five pillars of HHS’s comprehensive, science-based strategy for the opioid epidemic,” said Health and Human Services Secretary Alex Azar. “This new guidance reflects our commitment to ensuring those who need overdose-reversing drugs have them and provides practical steps that clinicians, patients, and the public can take to reduce the risk of an overdose.” In April 2017, HHS announced its 5-Point Strategy to Combat the Opioids Crisis. Those efforts include: better addiction prevention, treatment, and recovery services; better data; better pain management; better targeting of overdose reversing drugs; and better research. In April 2018, Surgeon General VADM Jerome Adams issued an unprecedented advisory encouraging more individuals, including family, friends, and those who are personally at risk for an opioid overdose to carry naloxone. Today’s guidance will bolster HHS’ ongoing efforts to combat the opioid crisis and expand the use of naloxone. To view the guidance, click here. To learn more about HHS’s efforts to combat the opioid crisis, visit www.hhs.gov/opioids
|
HRSA led research published in the Journal of Women's Health found that, when compared with women who had never given birth, mothers of older children had a higher prevalence of cardiovascular risk factors, including unhealthy diet (75.6% vs. 68.8%) and smoking (28.1% vs. 21.9%). Similar results were found for mothers of infants and toddlers, indicating that pregnancy and childrearing may be associated with less favorable cardiovascular risk factors among reproductive-aged U.S. mothers.
Previous research has shown that certain pregnancy-related physiological changes, such as higher cholesterol, can persist after delivery. Physiological changes and unhealthy behaviors associated with pregnancy and childrearing increase the likelihood of cardiovascular disease later in life.
The findings underscore the importance of emphasizing healthy behaviors and appropriate supports for women, during pregnancy and throughout parenthood, to ensure their health and wellbeing.
|
Our colleagues at the Administration of Community Living (ACL) are promoting this upcoming webinar about older adults who have been hard hit by the opioid epidemic. The webinar, with experts from Stanford University, will provide a forum to ask questions about opioid use in older adults and the applicability of the Chronic Pain Self-Management Program as a tool for prevention and management.
|
Watch the first webinar of the National Prevention Week (NPW) 2019 series to learn about the intersection between suicide prevention and opioid misuse prevention, as well as key strategies to prevent suicide and opioid misuse in your community. Understand what prevention strategies and approaches can be used to address these two growing public health issues at the national, state, and local levels. Plus, learn about the latest data trends and effective prevention strategies and approaches to implement to prevent opioid/suicide-related deaths in your community.
Visit the National Prevention Week webinars page for the latest updates on the NPW 2019 webinar series and more archived webinars about substance use prevention and the promotion of positive mental health.
|
The U.S. Department of Health and Human Services (HHS) is soliciting written comments on the proposed objectives for Healthy People 2030. The public comment period will be open from December 3, 2018 through January 17, 2019. You are invited to review and comment on the proposed objectives, and you may also propose additional objectives for consideration.…
What Do We Really Know About
“The Cycle of Violence”?
Research & Practical Implications
It is commonly said that youth who are exposed to interparental domestic violence are at an increased risk of experiencing dating violence in their romantic relationships. This phenomenon is often referred to as “the cycle of violence” or intergenerational transmission of violence. There is ample evidence supporting “the cycle of violence” hypothesis; yet, most youth exposed to interparental domestic violence do not go on to experience violence in their romantic relationships. How can we explain these seemingly opposing findings?
Specifically, webinar attendees will learn:
- What factors can increase or decrease adolescents’ risk of dating violence.
- How individuals can help prevent or break the cycle of violence.
- How to help promote post-traumatic growth and resilience in adolescents’ romantic relationships.
Presenters: Megan Haselschwerdt, Ph.D., Assistant Professor in Child and Family Studies, The University of Tennessee, Knoxville.
Who should attend: Violence prevention specialists, professionals working with couples and families impacted by domestic violence, marriage and healthy relationship grantees, family life educators, high school guidance counselors, Family and Consumer Sciences students and educators, and teen dating violence researchers
When: Wednesday, January 9, 2019, 4:00 pm Eastern/1:00 pm Pacific
Duration: 60 minutes
|
Requests for Applications: Building a Breastfeeding Support Model for Community Health Centers
With support from the Centers for Disease Control and Prevention (CDC), Division of Nutrition, Physical Activity and Obesity (DNPAO), the National Association of County and City Health Officials (NACCHO) is pleased to announce a funding opportunity to community health centers (CHCs) to pilot a breastfeeding support model. In addition to funding, NACCHO will provide technical assistance (TA) to CHCs as they explore and adopt policy system and environmental change solutions to increase their capacity to provide consistent and coordinated breastfeeding promotion and support services to the families they serve.
NACCHO will select three to six CHCs to design and implement a 6-month breastfeeding promotion and support project. Organizations will be awarded up to $20,000 each. Examples of activities may include implementation of evidence-based breastfeeding support policies, training of staff on basic and advanced lactation care, inclusion of breastfeeding support data into electronic medical records, implementation of supportive policies for breastfeeding employees and clients; enhancement of internal and external collaborations for breastfeeding continuity of care, and activities that connect breastfeeding mothers to relevant resources within their communities.
Online application submissions are due on January 6, 2019.
You will be prompted to create a free NACCHO online account in order to apply.
|
|
.png)
No hay comentarios:
Publicar un comentario